Evaxion Biotech AS
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $3,026 | $153 | $50 | $73 |
Gross Profit | 3,026 | 153 | 50 | 73 |
EBITDA | -1,647 | -4,540 | 1,222 | -4,264 |
EBIT | -1,736 | -4,577 | 1,178 | -4,364 |
Net Income | -1,941 | -6,193 | 1,194 | -4,560 |
Net Change In Cash | 3,026 | 153 | 50 | 73 |
Free Cash Flow | -2,006 | |||
Cash | 4,576 | 7,993 | 11,730 | 5,582 |
Basic Shares | 5,525 | 5,411 | 4,663 | 2,733 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $73 | $0 | $0 | $0 |
Gross Profit | 72 | -571 | -343 | -105 |
EBITDA | -21,403 | -22,584 | -24,168 | -16,463 |
EBIT | -22,018 | -23,155 | -24,511 | -16,568 |
Net Income | -22,125 | -23,169 | -24,532 | -15,018 |
Net Change In Cash | 73 | 0 | 0 | 0 |
Free Cash Flow | -17,778 | -26,066 | -23,293 | -12,831 |
Cash | 5,583 | 13,184 | 32,166 | 5,834 |
Basic Shares | 2,733 | 2,363 | 1,949 | 1,619 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.04 |
2024-06-30 | -$0.12 |
2024-03-31 | $0.30 |
2023-12-31 | -$1.60 |
